US approves updated Pfizer, Moderna shots targeting Omicron / Photo: Joseph Prezioso - AFP/File
-
Russia jails veteran who threatened Putin with mutiny
-
Three things we learned from the Austrian F1 Grand Prix
-
Five shot dead at German youth welfare site, two suspects arrested
-
Burnham pledges radical devolution of UK govt if PM
-
New Zealand thrash England to deny Stokes a fairytale finish
-
Polish businesses press Warsaw, Kyiv to end political rift
-
Tour de France 'ready to adapt' amid extreme heatwave
-
Hovland beats Scheffler in playoff for PGA Travelers title
-
Stocks rise, oil climbs after US-Iran clashes
-
New Zealand thrash England for series win as Stokes bows out
-
Man City hire Maresca to start new era after Guardiola
-
Trump says Iran meeting to take place in Qatar
-
Pegula slams Vondrousova's 'harsh' doping ban
-
Spain raises 2026 growth forecast despite Mideast war turmoil
-
Chavez-era housing complex in ruins after Venezuela quakes
-
Kenya-US rare earths deal challenged in court over secrecy
-
Sinner, Djokovic set to start Wimbledon title charge
-
Santner strikes as New Zealand eye England series win
-
Pakistan launches deadliest attack on Afghanistan in months
-
Broos may change decision to quit as South Africa coach
-
Strauss 'dumbfounded' by timing of Stokes's England exit
-
French swim star Marchand suffers injury scare before Europeans
-
Monza turn to Juric for return to Serie A
-
France skipper Dupont to miss Nations Championship
-
Stocks mixed, oil edges up after US-Iran clashes
-
Springbok milestones loom for Willemse and Kolbe against England
-
Catholic traditionalists risk schism in Church
-
Tennis players end Wimbledon prize-money protest
-
Europe's deadly heatwave scorches eastern flank, takes aim at Ukraine
-
Pogacar rides with Del Toro and Yates in quest for fifth Tour de France
-
PSG in talks with Leipzig to buy Ivory Coast star Diomande
-
Australia to host Brazil double-header after World Cup
-
Venezuela search teams scramble as hope fades of finding quake survivors
-
Stocks rise and oil edges up as US, Iran call end to latest attacks
-
Bondi Beach attack survivor tells of 'trauma' of online AI images
-
South Korea to invest nearly $1.2 tn in chips, AI data centres
-
Pakistan strikes on eastern Afghanistan kill dozens
-
Russia rallies support for army with 'patriotic' tourist routes
-
Cape Verde, Africa's outlier in LGBTQ tolerance
-
Brazil, Germany eye World Cup last 16 as Netherlands face Morocco
-
South Korea demands change after dismal World Cup exit
-
Washington says US, Iran pausing strikes, talks to proceed
-
Stocks mixed and oil rises as US, Iran call end to latest attacks
-
EU, China trade tensions loom over minister visit
-
For sale on Facebook: monkeys, rhino horn and dead pangolins
-
Israelis, Palestinians torn over sacred shrine in city of Hebron
-
In Sudan's Kordofan, a key city reels as paramilitary offensive looms
-
Scheffler to face Hovland in Monday playoff for PGA Travelers title
-
Ryu Hae-ran wins Women's PGA Championship
-
'Burnt out' Stokes leaves England facing tricky questions
US approves updated Pfizer, Moderna shots targeting Omicron
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.
The two updated booster shots aimed at providing "better protection against Covid-19 caused by the Omicron variant" are approved for people age 12 and above for the Pfizer shot and 18 and older for Moderna, the Food and Drug Administration (FDA) said in a statement.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States and which the FDA predicts will circulate in the coming months.
Earlier this summer the US health department announced it had purchased 105 million doses from Pfizer and 66 million from Moderna for use over the fall and winter.
The vaccines have yet to be recommended by the Centers for Disease Control and Prevention, the nation's health protection agency. But an independent panel of experts is scheduled to be convened by the CDC on Thursday to discuss the updates.
CDC director Rochelle Walensky will be in charge of giving the final green light.
The new versions of the vaccines could potentially be available in the United States as early as next week.
"Receiving a booster that specifically targets the Omicron BA.4/.5 variant, currently the most prevalent strain of SARS-CoV-2, is an important public health measure that people can take to help protect themselves, especially as we head into a season filled with indoor gatherings," Moderna chief executive Stephane Bancel said in a statement.
The vaccines currently in circulation target the initial strain of the virus that first appeared in Wuhan, China. But they have gradually proven to be less effective against the variants that have appeared over time, due to rapid evolution of the virus.
In contrast to the Alpha and Delta variants, which eventually waned, Omicron and its subvariants have come to dominate infections worldwide in 2022.
Pfizer and Moderna have also filed for approval of their updated vaccines with the European Medicines Agency.
R.Lee--AT
